Profile data is unavailable for this security.
About the company
Shenzhen Lifotronic Technology Co Ltd is a China-based company mainly engaged in the research, development, manufacturing and marketing of medical devices. The Company focuses on the development and technological innovation of treatment and rehabilitation equipment, in vitro diagnostic equipment and supporting detection reagents. The Company's products mainly include wound and skin treatment products, perioperative and intensive care products, pain and rehabilitation treatment products and in vitro diagnostic products. The Company mainly conducts its businesses in domestic and overseas markets.
- Revenue in CNY (TTM)1.17bn
- Net income in CNY347.69m
- Incorporated2008
- Employees1.48k
- LocationShenzhen Lifotronic Technology Co Ltd4F, Building 15No. 1008, Xili Songbai RoadNanshan DistrictShenzhen 518110ChinaCHN
- Phone+86 75 529060052
- Fax+86 75 529060036
- Websitehttp://www.lifotronic.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wuhan Keqian Biology Co Ltd | 989.49m | 347.63m | 7.80bn | 923.00 | 22.38 | 2.00 | -- | 7.89 | 0.748 | 0.748 | 2.12 | 8.37 | 0.213 | 1.93 | 3.03 | 1,072,036.00 | 7.47 | 13.29 | 8.81 | 15.49 | 68.82 | 76.49 | 35.09 | 45.71 | 3.65 | -- | 0.0508 | 24.76 | 6.27 | 7.67 | -3.32 | 0.3556 | 27.17 | -- |
| Youcare Pharmaceutical Group Co Ltd | 4.04bn | 168.83m | 7.82bn | 3.18k | 46.26 | 2.14 | -- | 1.94 | 0.3757 | 0.3757 | 8.97 | 8.13 | 0.6518 | 2.07 | 4.09 | 1,269,471.00 | 2.76 | 7.11 | 4.15 | 11.65 | 59.54 | 64.14 | 4.24 | 8.07 | 1.42 | -- | 0.2079 | 60.95 | -7.61 | 1.05 | -44.84 | -7.16 | 23.40 | -- |
| Vcanbio Cell & Gene Engineering Corp Ltd | 1.61bn | 109.23m | 8.16bn | 2.21k | 74.67 | 2.21 | -- | 5.07 | 0.2334 | 0.2334 | 3.44 | 7.88 | 0.3034 | 2.01 | 2.86 | 728,818.10 | 1.97 | 1.13 | 2.79 | 1.61 | 67.97 | 67.76 | 6.51 | 3.84 | 1.52 | 6.93 | 0.0284 | 0.00 | 2.24 | 3.78 | -5.78 | 12.43 | -7.11 | -- |
| Lushang Freda Pharmaceutical Co Ltd | 4.20bn | 233.09m | 8.17bn | 3.65k | 35.07 | 2.01 | -- | 1.95 | 0.2293 | 0.2293 | 4.13 | 4.01 | 0.4446 | 0.8832 | 7.75 | 1,149,606.00 | 3.02 | 0.6992 | 5.84 | 5.12 | 48.44 | 20.23 | 6.79 | 3.45 | 2.67 | -- | 0.1251 | 40.33 | -64.65 | -12.29 | 567.44 | 13.36 | 44.40 | 14.87 |
| Shenzhen Lifotronic Technology Co Ltd | 1.17bn | 347.69m | 8.18bn | 1.48k | 23.52 | 4.29 | -- | 6.97 | 0.8120 | 0.8120 | 2.75 | 4.46 | 0.5409 | 2.32 | 7.90 | 792,478.60 | 15.97 | 13.82 | 19.66 | 16.33 | 65.70 | 61.01 | 29.52 | 26.10 | 3.51 | -- | 0.1004 | 41.51 | 16.55 | 28.78 | 30.66 | 32.27 | -7.91 | -- |
| Guangxi Wuzhou Zhongheng Group Co Ltd | 3.23bn | 156.14m | 8.21bn | 2.89k | 52.40 | 1.25 | -- | 2.54 | 0.0454 | 0.0454 | 0.9413 | 1.91 | 0.2766 | 1.96 | 3.41 | 1,120,149.00 | 0.9542 | 2.26 | 1.51 | 3.38 | 53.66 | 72.05 | 3.45 | 7.27 | 2.38 | -- | 0.1795 | 45.67 | 14.10 | -1.26 | 6.69 | -32.76 | -4.56 | -30.12 |
| North China Pharmaceutical Co Ltd | 10.02bn | 17.62m | 8.22bn | 10.16k | 466.41 | 1.54 | -- | 0.8204 | 0.0103 | 0.0103 | 5.84 | 3.11 | 0.4693 | 2.71 | 4.31 | 986,082.90 | 0.3543 | -0.2978 | 0.8122 | -0.7042 | 30.26 | 35.73 | 0.755 | -0.5985 | 0.5425 | 1.43 | 0.6473 | -- | -3.62 | 1.89 | 100.71 | -49.62 | 4.22 | -19.73 |
Data as of May 31 2024. Currency figures normalised to Shenzhen Lifotronic Technology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
14.87%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 41.93m | 9.85% |
| Guotai Asset Management Co., Ltd.as of 31 Dec 2023 | 5.81m | 1.37% |
| Truvalue Asset Management Co. Ltd.as of 31 Dec 2023 | 4.04m | 0.95% |
| China Southern Asset Management Co., Ltd.as of 31 Dec 2023 | 2.64m | 0.62% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 2023 | 2.49m | 0.58% |
| China Asset Management Co., Ltd.as of 29 Feb 2024 | 2.23m | 0.52% |
| Great Wall Fund Management Co., Ltd.as of 31 Dec 2023 | 1.39m | 0.33% |
| Wanjia Asset Management Co., Ltd.as of 31 Dec 2023 | 1.20m | 0.28% |
| Maxwealth Fund Management Co., Ltd.as of 31 Dec 2023 | 849.51k | 0.20% |
| Peng Yang Amc Fund Management Co. Ltd.as of 31 Dec 2023 | 683.46k | 0.16% |
More ▼
Data from 31 Dec 2023 - 29 Apr 2024Source: FactSet Research Systems Inc.
